Stockscreener 앱 받기
9.795
8.29%
-0.885
시장 영업 전:
9.49
-0.305
-3.11%
전일 마감가:
$10.68
열려 있는:
$10.5
하루 거래량:
77,325
Relative Volume:
1.89
시가총액:
$31.14M
수익:
-
순이익/손실:
$-68.80M
주가수익비율:
-8.3718
EPS:
-1.17
순현금흐름:
$-59.06M
1주 성능:
+6.35%
1개월 성능:
+4.42%
6개월 성능:
+2,169%
1년 성능:
+1,151%
1일 변동 폭
$9.72
$10.57
1주일 범위
$9.125
$10.71
52주 변동 폭
$0.257
$10.71
Passage Bio Inc Stock (PASG) Company Profile
명칭
Passage Bio Inc
전화
(267) 866-0312
주소
ONE COMMERCE SQUARE, PHILADELPHIA, PA
PASG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
9.795 | 33.95M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-09-03 | 개시 | Rodman & Renshaw | Buy |
| 2022-03-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-19 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-07-01 | 개시 | Raymond James | Outperform |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-03-04 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-02-04 | 개시 | Guggenheim | Buy |
| 2021-01-25 | 개시 | Wedbush | Outperform |
| 2021-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-08-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-25 | 개시 | Chardan Capital Markets | Buy |
| 2020-03-24 | 개시 | Cowen | Outperform |
| 2020-03-24 | 개시 | Goldman | Buy |
| 2020-03-24 | 개시 | JP Morgan | Overweight |
모두보기
Passage Bio Inc 주식(PASG)의 최신 뉴스
Financial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG) - Defense World
Passage Bio (PASG) Price Target Increased by 21.85% to 40.39 - Nasdaq
What drives Passage Bio Inc stock priceGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
How Passage Bio Inc. stock compares to industry benchmarksPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Passage Bio Inc Stock Analysis and ForecastInstitutional Buying Trends & Capitalize On Fast Trends - earlytimes.in
Can Divgi TorqTransfer Systems Limited Compete Globally or Is It a Local Player OnlyDividend Reinvestment Plans & Use Smart Algorithms to Pick Better Stocks - earlytimes.in
Is Passage Bio Inc. stock a safe haven assetMarket Growth Report & Pattern Based Trade Signal System - Newser
Why Passage Bio Inc. stock is a must watch in 2025Market Rally & Free Community Supported Trade Ideas - Newser
Will Passage Bio Inc. stock sustain high P E ratiosEarnings Summary Report & Safe Entry Momentum Stock Tips - moha.gov.vn
Passage Bio to Present at Two Major Investor Conferences - MSN
Gains Recap: Why Passage Bio Inc. stock is seen as undervalued2025 Momentum Check & Free High Accuracy Swing Entry Alerts - moha.gov.vn
Why Passage Bio Inc. stock is rated strong buyJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - moha.gov.vn
How currency fluctuations impact Passage Bio Inc. stockMarket Risk Analysis & Verified Stock Trade Ideas - moha.gov.vn
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - moha.gov.vn
Brokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $42.67 - Defense World
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MyChesCo
Passage Bio (PASG) Price Target Decreased by 45.15% to 33.15 - MSN
Lucid Capital Markets initiates Passage Bio stock with Buy rating By Investing.com - Investing.com Canada
Lucid Capital Markets initiates Passage Bio stock with Buy rating - Investing.com India
Passage Bio, Inc. (PASG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How Passage Bio Inc. stock compares to market leadersInsider Selling & AI Powered Market Trend Analysis - newser.com
Is Passage Bio Inc. stock bottoming out2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates - MSN
How Passage Bio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
What momentum shifts mean for Passage Bio Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Chardan Capital Expects Reduced Earnings for Passage Bio - Defense World
Passage Bio Inc. stock trendline breakdownWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Ranking Passage Bio Inc. among high performing stocks via toolsQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Passage Bio, Inc.Common Stock (NQ: PASG - FinancialContent
Using economic indicators to assess Passage Bio Inc. potentialQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
How Passage Bio Inc. stock reacts to global recession fearsEarnings Miss & Real-Time Volume Triggers - newser.com
Chardan Capital Raises Passage Bio (NASDAQ:PASG) Price Target to $21.00 - Defense World
Passage Bio (NASDAQ:PASG) Price Target Raised to $21.00 - Defense World
Can Passage Bio Inc. stock attract ESG capital inflowsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Fundação Cultural do Pará
Is Passage Bio Inc. stock a contrarian buyJuly 2025 Final Week & Weekly Stock Breakout Alerts - Fundação Cultural do Pará
What is Wedbush’s Forecast for Passage Bio FY2025 Earnings? - Defense World
Passage Bio Inc (PASG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):